Pharmafile Logo

Event: Intellus Worldwide Summit 2019

May 2, 2019 | Pharma, healthcare 

Visit us on stand number 311

We are delighted to be exhibiting at the Intellus Worldwide Summit in Philadelphia, USA from 19th-21st May. Representing Research Partnership at the event will be Liza Pliss, Director and Head of our New York Office, Sabera Hyderally, Director, Head of MedTech Division North America and Emily Hoffman, Associate Director.

In keeping with the theme of the Summit, Liza Pliss will be present at stand 311 to discuss our User Experience (UX) capabilities. She is an expert in UX and Usability research having conducted multiple studies to improve the experience of digital resources for healthcare professionals and consumers. Liza recently presented the paper ‘Optimize your digital assets with UX research’ at the PMR Conference in New Jersey, USA and you can view the audio presentation here »

Find out more about the event here: https://bit.ly/2GYucby

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates

Exploring MINT: Part 4 – Turkey

In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in...

Getting to grips with Russia’s healthcare market

As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn't...

Exploring MINT: Part 3 – Nigeria

In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.

Exploring MINT: Part 2 – Indonesia

In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...

Free Thinking: Leveraging the ASEAN Market

If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to...

Free Thinking: Biosimilars: Friend or foe to healthcare?

Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.